Hemochromatosis: Clinical implications of genetic testing

Adams, Paul C.
July 1998
CMAJ: Canadian Medical Association Journal;07/28/98, Vol. 159 Issue 2, p156
Academic Journal
Editorial. Discusses genetic testing for the disease Hemochromatosis. Hemochromatosis as a very common disease affecting Canadians; Detection of the disease by a blood test; Reasons of discrepancy of its genetic prevalence; Population screening studies; The problem of the misdiagnosis of hemochromatosis; How the genetic test works; The belief that genetic testing should be offered to any patient who is suspected to have the disease; The development of an ideal strategy for screening the general population.


Related Articles

  • Should asymptomatic haemochromatosis be treated? Seamark, Clare J // BMJ: British Medical Journal (International Edition);05/13/2000, Vol. 320 Issue 7245, p1314 

    Discusses issues associated with the diagnosis and treatment of hereditary haemochromatosis. Description of a general practitioner's experience in the treatment of asymptomatic haemochromatosis; Patient's view on the treatment process; Genetic screening for the disease; Trial evidence on the...

  • Population screening for hemachromatosis: The evolving role of genetic analysis. Davis, Jessica G. // Annals of Internal Medicine;12/01/98, Vol. 129 Issue 11, p905 

    Examines the role of genetic analysis in the population screening for hemochromatosis. Concerns on the possibility of medical and genetic discrimination in such screening tests; Pitfalls of population screening for hereditary hemochromatosis; Challenges posed by genetic diseases and new...

  • Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis. King, Caitriona; Barton, David E // BMC Medical Genetics;2006, Vol. 7, p81 

    Background: Hereditary haemochromatosis (HH) is a recessively-inherited disorder of iron over-absorption prevalent in Caucasian populations. Affected individuals for Type 1 HH are usually either homozygous for a cysteine to tyrosine amino acid substitution at position 282 (C282Y) of the HFE...

  • Hereditary hemochromatosis. Burke, Wylie; Thomson, Elizabeth; Khoury, Muin J.; McDonnell, Sharon M.; Press, Nancy; Adams, Paul C.; Barton, James C.; Beutler, Ernest; Brittenham, Gary; Buchanan, Allen; Wright Clayton, Ellen; Cogswell, Mary E.; Meslin, Eric M.; Motulsky, Arno G.; Sigal, Elliott; Wilfond, Benjamin S.; Collins, Francis S. // JAMA: Journal of the American Medical Association;7/8/98, Vol. 280 Issue 2, p172 

    Evaluates the role of genetic testing in screening for hereditary hemochromatosis to help guide clinicians, policymakers, and researchers. Objective; Participants; Evidence; Consensus process; Conclusions.

  • The debate over screening for hemochromatosis.  // Patient Care for the Nurse Practitioner;Aug2003, Vol. 6 Issue 8, p8 

    The article talks about screening for hemochromatosis. A consensus statement prepared by an expert panel convened by the CDC and the National Human Genome Research Institute in 1998 concluded that genetic testing is not recommended at this time in population-based screening for hereditary...

  • Screening Blood Donors for Hereditary Hemochromatosis: Decision Analysis Model Comparing Genotyping to Phenotyping. Adams, Paul C.; Valberg, Leslie S. // American Journal of Gastroenterology;Jun1999, Vol. 94 Issue 6, p1593 

    OBJECTIVE: The identification of a gene for hereditary hemochromatosis in 69-100% of typical hemochromatosis patients has resulted in a genotypic test to identify persons with the typical missense mutation. Population screening by genotyping has the potential to reduce screening costs because of...

  • Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases? Cadet, E.; Capron, D.; Gallet, M.; Omanga-Léké, M.-l.; Boutignon, H.; Julier, C.; Robson, K. J. H,.; Rochette, J. // Journal of Medical Genetics;May2005, Vol. 42 Issue 5, p390 

    Background: Genetic testing can determine those at risk for hereditary haemochromatosis (HH) caused by HFE mutations before the onset of symptoms. However, there is no optimum screening strategy, mainly owing to the variable penetrance in those who are homozygous for the HFECys282Tyr (C282Y)...

  • Screening for Hemochromatosis: Recommendation Statement.  // American Family Physician;6/1/2007, Vol. 75 Issue 11, p1696 

    The article presents a reprint of the article "Screening for Hemochromatosis: Recommendation Statement," which appeared in the 2006 issue of the "Annals of Internal Medicine." It focuses on the hemochromatosis screening methods issued by the U.S. Preventive Services Task Force. It states that...

  • The Impact of Test Outcome Certainty on Interest in Genetic Testing Among College Women. Paglierani, Lisa M.; Kalkwarf, Heidi J.; Rosenthal, Susan L.; Huether, Carl A.; Wenstrup, Richard J. // Journal of Genetic Counseling;Apr2003, Vol. 12 Issue 2, p131 

    Determines the interest of undergraduate women in genetic testing for hemochromatosis and osteoporosis. Clinical features of the diseases; Limits of a genetics test; Predictors of genetics test acceptance; Implications for the development of population genetic screening tests.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics